Urenco Isotopes

About Urenco Isotopes

Urenco Isotopes sits in Isotope Supply, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Reuters Health · 2026-09-20
  Urenco Isotopes expands cyclotron capacity to meet Lu-177 demand
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Endpoints News · 2026-10-11
  Urenco Isotopes announces Phase II readout for lead theranostic candidate
  The work builds on more than a decade of radiochemistry collaboration.
• FierceBiotech · 2026-11-06
  Urenco Isotopes appoints new Chief Medical Officer ahead of pivotal trial
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• BioPharma Reporter · 2026-12-01
  Urenco Isotopes signs supply agreement to support late-stage trials
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Imaging Wire · 2026-05-20
  Urenco Isotopes closes Series C round to scale radiopharma manufacturing
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.